Cargando…
Managing therapeutic resistance in breast cancer: from the lncRNAs perspective
Breast cancer (BC) is the most common female malignancy and the second leading cause of cancer-related death worldwide. In spite of significant advances in clinical management, the mortality of BC continues to increase due to the frequent occurrence of treatment resistance. Intensive studies have be...
Autores principales: | Peng, Liyuan, Jiang, Jingwen, Tang, Bo, Nice, Edouard C., Zhang, Yuan-Yuan, Xie, Na |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482807/ https://www.ncbi.nlm.nih.gov/pubmed/32929354 http://dx.doi.org/10.7150/thno.49922 |
Ejemplares similares
-
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
por: Li, Sui, et al.
Publicado: (2022) -
Perspectives of LncRNAs for therapy
por: Ilieva, Mirolyuba, et al.
Publicado: (2022) -
Potential Therapeutic Targeting of lncRNAs in Cholesterol Homeostasis
por: Ye, Wen-Chu, et al.
Publicado: (2021) -
LncRNAs regulate metabolism in cancer
por: Lin, Wenyu, et al.
Publicado: (2020) -
LncRNAs as Therapeutic Targets and Potential Biomarkers for Lipid-Related Diseases
por: Huang, Shi-Feng, et al.
Publicado: (2021)